Search Within

Ping Chi

Formats
  1. Journal Article (91)
  2. Meeting Abstract (81)
  3. Review (2)
  4. Miscellaneous (1)
Groups
  1. Department of Medicine (175)
  2. GSK Faculty (175)
  3. Human Oncology and Pathogenesis Program (175)
  4. Sarcoma Service (175)
  5. Solid Tumor Oncology Division (175)
  6. Tow Center for Developmental Oncology (TCDO) (175)

More Groups

People
  1. William Tap (70)
  2. Cristina Antonescu (67)
  3. Sandra D'Angelo (60)
  4. Mrinal Gounder (58)
  5. Mary Keohan (57)
  6. Mark Dickson (56)

More People

Years
  1. 2025 (6)
  2. 2024 (18)
  3. 2023 (19)
  4. 2022 (30)
  5. 2021 (20)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (18)
  3. Annals of Oncology (14)
  4. Cancer Research (11)
  5. Genes Chromosomes and Cancer (5)
  6. JCO Precision Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (42)
  2. American Association for Cancer Research (35)
  3. Oxford University Press (20)
  4. Nature Publishing Group (16)
  5. Elsevier Inc. (8)
  6. Cell Press (6)

More Publishers

Results (175)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte MeĢrida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • INSIGHT: A phase 3, randomized, multicenter, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib harboring KIT exon 11 + 17 and/or 18 mutations
    Meeting Abstract

    George, S.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Reichmann, W.; Sprott, K.; Achour, H.; Sherman, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
    Journal Article

    Gelderblom, H.; Jones, R. L.; Blay, J. Y.; George, S.; von Mehren, M.; Zalcberg, J. R.; Kang, Y. K.; Razak, A. A.; Trent, J.; Attia, S.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies
    Journal Article

    Dermawan, J. K.; Chi, P.; Tap, W. D.; Rosenbaum, E.; D'Angelo, S.; Alektiar, K. M.; Antonescu, C. R.
    Journal of Pathology (2023)

    Fulltext@MSK | Save
  • Distinct genomic alterations in radiation-induced angiosarcoma compared to other radiation-associated sarcoma histologies: Rationale for individualized therapeutic targeting
    Meeting Abstract

    Dermawan, J.; Chi, P.; Tap, W.; Rosenbaum, E.; D'Angelo, S.; Alektiar, K.; Antonescu, C.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
    Journal Article

    Li, D.; Zhan, Y.; Wang, N.; Tang, F.; Lee, C. J.; Bayshtok, G.; Moore, A. R.; Wong, E. W. P.; Pachai, M. R.; Xie, Y.; more...
    Science Advances (2023)

    Fulltext@MSK | Save